I think we probably agree on more than we disagree on.
I was objecting specifically to the claims that pharma substantially benefits from taxpayer funded research and would sue non-profits out of existence.
I totally agree that the incentives are the problem! The best step forward would be to federally negotiate prices based on relative benefit. Next we could look at outcome based compensation. I think these changes would address 90% of the problem.
I was objecting specifically to the claims that pharma substantially benefits from taxpayer funded research and would sue non-profits out of existence.
I totally agree that the incentives are the problem! The best step forward would be to federally negotiate prices based on relative benefit. Next we could look at outcome based compensation. I think these changes would address 90% of the problem.